{"id":1751,"date":"2026-06-26T19:11:28","date_gmt":"2026-06-26T18:11:28","guid":{"rendered":"http:\/\/seamlessbio.de\/?page_id=1751"},"modified":"2026-07-06T21:32:37","modified_gmt":"2026-07-06T20:32:37","slug":"pbmc","status":"publish","type":"page","link":"https:\/\/seamlessbio.de\/de\/pbmc\/","title":{"rendered":"Application PBMC"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1751\" class=\"elementor elementor-1751\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7ac59b3 e-con e-atomic-element e-flexbox-base e-96da18e \" data-id=\"7ac59b3\" data-element_type=\"e-flexbox\" data-e-type=\"e-flexbox\" data-interaction-id=\"7ac59b3\">\n    \t\t<div class=\"elementor-element elementor-element-2b3e0c8 elementor-widget elementor-widget-html\" data-id=\"2b3e0c8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<!-- YOAST SEO SETTINGS\nSlug:             applications\/pbmc-immunology\nFocus Keyword:    PBMC immunology assays serum ELISpot endotoxin human serum AB\nSEO Title (EN):   PBMC Culture & Immunology Assays \u2014 Serum Selection Guide | SeamlessBio\nMeta Desc (EN):   Complete serum guide for PBMC isolation, ELISpot, cytokine assays, NK cell and OPA assays. FBS Very Low Endotoxin \u22641 EU\/mL, Human Serum AB HI. Protocols and product recommendations. SeamlessBio.\nTitle length:     80 chars\nDesc length:      210 chars\n-->\n<section class=\"sb-pbmc\">\n<style>\n.sb-pbmc,.sb-pbmc *,.sb-pbmc *::before,.sb-pbmc *::after{box-sizing:border-box;}\n.sb-pbmc{background:#fff;padding:70px 40px 90px;font-family:Arial,sans-serif;color:#202020;}\n.sb-pbmc .wrap{max-width:1200px;width:100%;margin:0 auto;}\n.sb-pbmc .bc{display:flex;flex-wrap:wrap;gap:8px;margin:0 0 24px;color:#777;font-size:14px;}\n.sb-pbmc .bc a{color:#18b7b2!important;text-decoration:none!important;font-weight:700;}\n.sb-pbmc .bc strong{color:#111;font-weight:800;}\n.sb-pbmc .hero{padding:64px 56px;margin-bottom:48px;border-radius:30px;background:linear-gradient(135deg,#18b7b2 0%,#65d3cf 52%,#e9fbfa 100%);color:#fff;}\n.sb-pbmc .hero .ey{display:inline-block;margin-bottom:14px;font-size:13px;font-weight:900;text-transform:uppercase;letter-spacing:1.8px;}\n.sb-pbmc .hero h1{margin:0 0 18px;color:#fff;font-size:clamp(26px,3.2vw,40px);line-height:1.1;font-weight:900;letter-spacing:-1px;max-width:840px;}\n.sb-pbmc .hero .sub{max-width:720px;margin:0 0 30px;color:#fff;font-size:17px;line-height:1.65;}\n.sb-pbmc .hbtns{display:flex;flex-wrap:wrap;gap:14px;}\n.sb-pbmc .btn1{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;background:#18b7b2;color:#fff!important;text-decoration:none!important;text-transform:uppercase;font-size:13px;font-weight:900;letter-spacing:.6px;transition:all .25s;}\n.sb-pbmc .btn1:hover{background:#139b97;transform:translateY(-2px);}\n.sb-pbmc .btn2{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;background:transparent;border:2px solid #fff;color:#fff!important;text-decoration:none!important;text-transform:uppercase;font-size:13px;font-weight:900;letter-spacing:.6px;transition:all .25s;}\n.sb-pbmc .btn2:hover{background:#fff;color:#139b97!important;transform:translateY(-2px);}\n.sb-pbmc .warn{background:rgba(245,166,35,.1);border-left:4px solid #f5a623;border-radius:8px;padding:18px 22px;margin-bottom:32px;font-size:14px;color:#444;line-height:1.7;}\n.sb-pbmc .warn strong{color:#111;display:block;margin-bottom:6px;font-size:15px;}\n.sb-pbmc .cards{display:grid;grid-template-columns:repeat(4,1fr);gap:22px;margin-bottom:48px;}\n.sb-pbmc .card{min-height:210px;padding:28px;border-radius:24px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);transition:all .25s;}\n.sb-pbmc .card:hover{background:#18b7b2;color:#fff;transform:translateY(-6px);box-shadow:0 18px 40px rgba(24,183,178,.22);}\n.sb-pbmc .card .num{display:inline-flex;margin-bottom:24px;color:#18b7b2;font-size:13px;font-weight:900;}\n.sb-pbmc .card:hover .num{color:#fff;}\n.sb-pbmc .card h3{margin:0 0 12px;color:inherit;font-size:18px;line-height:1.3;font-weight:900;}\n.sb-pbmc .card p{margin:0;color:inherit;font-size:14px;line-height:1.6;opacity:.88;}\n.sb-pbmc .two{display:grid;grid-template-columns:1.1fr 0.9fr;gap:34px;margin-bottom:34px;}\n.sb-pbmc .two>div{padding:34px;border-radius:26px;background:#fff;border:1px solid #eee;}\n.sb-pbmc .two h2{margin:0 0 14px;color:#111;font-size:24px;font-weight:900;}\n.sb-pbmc .two h3{margin:0 0 14px;color:#111;font-size:20px;font-weight:900;}\n.sb-pbmc .two p{margin:0 0 12px;color:#555;font-size:15px;line-height:1.7;}\n.sb-pbmc .two ul{margin:0;padding:0;list-style:none;}\n.sb-pbmc .two li{position:relative;padding:10px 0 10px 22px;border-bottom:1px solid #eee;color:#555;font-size:14px;line-height:1.5;}\n.sb-pbmc .two li::before{content:\"\";position:absolute;left:0;top:18px;width:8px;height:8px;border-radius:50%;background:#18b7b2;}\n.sb-pbmc .two li a{color:#139b97!important;font-weight:700;text-decoration:none!important;}\n.sb-pbmc .two li a:hover{text-decoration:underline!important;}\n.sb-pbmc .sec{margin-bottom:34px;padding:34px;border-radius:26px;background:#fff;border:1px solid #eee;}\n.sb-pbmc .sec h2{margin:0 0 14px;color:#111;font-size:22px;font-weight:900;}\n.sb-pbmc .sec p{margin:0 0 12px;color:#555;font-size:15px;line-height:1.7;}\n.sb-pbmc .tw{overflow-x:auto;margin-top:16px;}\n.sb-pbmc table{width:100%;border-collapse:collapse;font-size:14px;min-width:480px;}\n.sb-pbmc thead th{background:#18b7b2;color:#fff;padding:11px 13px;text-align:left;font-weight:700;}\n.sb-pbmc tbody tr:nth-child(even){background:#f5fffe;}\n.sb-pbmc tbody tr:hover{background:#e8f9f8;}\n.sb-pbmc tbody td{padding:10px 13px;vertical-align:top;border-bottom:1px solid #e5e5e5;line-height:1.5;font-size:13px;}\n.sb-pbmc table a{color:#18b7b2;text-decoration:none;font-weight:600;}\n.sb-pbmc table a:hover{color:#139b97;}\n.sb-pbmc .faq{margin-bottom:34px;padding:34px;border-radius:26px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);}\n.sb-pbmc .faq h2{margin:0 0 20px;color:#111;font-size:22px;font-weight:900;}\n.sb-pbmc .faq-item{border-bottom:1px solid #e0e0e0;padding:18px 0;}\n.sb-pbmc .faq-item:last-child{border-bottom:none;padding-bottom:0;}\n.sb-pbmc .faq-q{font-size:15px;font-weight:900;color:#111;margin-bottom:8px;}\n.sb-pbmc .faq-a{font-size:14px;color:#555;line-height:1.7;}\n.sb-pbmc .related{margin-bottom:34px;padding:28px 34px;border-radius:26px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);}\n.sb-pbmc .related h3{margin:0 0 16px;color:#111;font-size:18px;font-weight:900;}\n.sb-pbmc .rel-grid{display:grid;grid-template-columns:repeat(2,1fr);gap:12px;}\n.sb-pbmc .rel-grid a{display:flex;align-items:center;min-height:50px;padding:12px 16px;border-radius:12px;background:#fff;border:1px solid #e0e0e0;color:#111!important;text-decoration:none!important;font-size:13px;font-weight:700;transition:all .2s;}\n.sb-pbmc .rel-grid a:hover{border-color:#18b7b2;color:#139b97!important;}\n.sb-pbmc .cta{margin-top:16px;padding:54px 34px;border-radius:30px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);text-align:center;}\n.sb-pbmc .cta h2{margin:0 0 12px;color:#111;font-size:28px;font-weight:900;}\n.sb-pbmc .cta p{max-width:760px;margin:0 auto 26px;color:#555;font-size:15px;line-height:1.65;}\n.sb-pbmc .ctabtns{display:flex;flex-wrap:wrap;gap:14px;justify-content:center;}\n.sb-pbmc .ctab1,.sb-pbmc .ctab2{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;font-size:13px;font-weight:900;text-transform:uppercase;letter-spacing:.6px;text-decoration:none!important;transition:all .25s;}\n.sb-pbmc .ctab1{background:#18b7b2;color:#fff!important;}\n.sb-pbmc .ctab1:hover{background:#139b97;transform:translateY(-2px);}\n.sb-pbmc .ctab2{background:transparent;border:2px solid #18b7b2;color:#18b7b2!important;}\n.sb-pbmc .ctab2:hover{background:#18b7b2;color:#fff!important;transform:translateY(-2px);}\n@media(max-width:1100px){\n  .sb-pbmc .hero{padding:48px 36px;}\n  .sb-pbmc .cards{grid-template-columns:repeat(2,1fr);}\n  .sb-pbmc .two{grid-template-columns:1fr;}\n  .sb-pbmc .rel-grid{grid-template-columns:1fr;}\n}\n@media(max-width:700px){\n  .sb-pbmc{padding:50px 16px 70px;}\n  .sb-pbmc .hero{padding:40px 24px;border-radius:24px;}\n  .sb-pbmc .hero h1{font-size:25px;}\n  .sb-pbmc .hbtns{flex-direction:column;}\n  .sb-pbmc .btn1,.sb-pbmc .btn2{width:100%;}\n  .sb-pbmc .cards{grid-template-columns:1fr;}\n  .sb-pbmc .card{min-height:auto;padding:20px;}\n  .sb-pbmc .two>div,.sb-pbmc .sec,.sb-pbmc .faq{padding:20px;}\n  .sb-pbmc .cta{padding:36px 20px;}\n  .sb-pbmc .ctabtns{flex-direction:column;}\n  .sb-pbmc .ctab1,.sb-pbmc .ctab2{width:100%;}\n}\n<\/style>\n\n<div class=\"wrap\">\n  <div class=\"bc\">\n    <a href=\"http:\/\/seamlessbio.de\/\">Home<\/a><span>\/<\/span>\n    <a href=\"https:\/\/www.seamlessbio.de\/applications\/\">Applications<\/a><span>\/<\/span>\n    <strong>PBMC Immunology<\/strong>\n  <\/div>\n\n  <div class=\"hero\">\n    <span class=\"ey\">SeamlessBio \u2014 Solutions by Application<\/span>\n    <h1>PBMC Culture &amp; Immunology Assays \u2014 Serum Selection Guide<\/h1>\n    <p class=\"sub\">Peripheral blood mononuclear cells (PBMCs) are the primary cell system for human immunology research \u2014 T cell, B cell, NK cell, monocyte and dendritic cell biology. Used in vaccine immunogenicity studies, clinical trial immunomonitoring, CAR-T potency testing, ADCC\/CDC assays and infectious disease research. Serum quality is the single most variable factor in PBMC assay reproducibility.<\/p>\n    <div class=\"hbtns\">\n      <a href=\"https:\/\/www.seamlessbio.de\/about-us\/contact-imprint\/\" class=\"btn1\">Contact Us<\/a>\n      <a href=\"https:\/\/shop.seamlessbio.de\" class=\"btn2\">View in Shop<\/a>\n    <\/div>\n  <\/div>\n\n  <div class=\"warn\">\n    <strong>\u26a0 Most common cause of high ELISpot background and non-specific PBMC activation:<\/strong>\n    Endotoxin (LPS) in standard FBS activates monocytes and macrophages in PBMC preparations via TLR4 \u2014 triggering non-specific IFN-\u03b3, TNF-\u03b1 and IL-6 secretion. This creates elevated background spot counts in ELISpot assays and inflated cytokine readings in multiplex assays. Standard FBS contains 10\u2013100 EU\/mL in unselected lots. Solution: <a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">FBS Very Low Endotoxin \u22641 EU\/mL<\/a> or <a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-type-ab-male\">Human Serum AB Heat Inactivated<\/a>.\n  <\/div>\n\n  <div class=\"cards\">\n    <div class=\"card\">\n      <span class=\"num\">01<\/span>\n      <h3>Human Serum AB HI \u2014 Gold Standard<\/h3>\n      <p>Preferred for vaccine immunogenicity ELISpot and OPA. AB type \u2014 no anti-A\/B agglutination. Heat inactivated \u2014 no complement interference. Species-matched human matrix reflects in vivo immune conditions.<\/p>\n    <\/div>\n    <div class=\"card\">\n      <span class=\"num\">02<\/span>\n      <h3>FBS Very Low Endotoxin \u22641 EU\/mL<\/h3>\n      <p>When FBS is required: VLE grade eliminates TLR4-mediated monocyte activation \u2014 the primary cause of high background in ELISpot and multiplex cytokine assays. Single lot reservation for full campaign.<\/p>\n    <\/div>\n    <div class=\"card\">\n      <span class=\"num\">03<\/span>\n      <h3>Human Serum AB OTC \u2014 OPA<\/h3>\n      <p>Opsonophagocytosis assays require active human complement + human IgG together in the correct species context. Only Human Serum AB OTC native provides both \u2014 bovine serum cannot replicate human opsonisation.<\/p>\n    <\/div>\n    <div class=\"card\">\n      <span class=\"num\">04<\/span>\n      <h3>BSA Low Endotoxin for ELISA<\/h3>\n      <p>1\u20133% BSA Low Endotoxin \u22645 EU\/mg as ELISA blocking buffer. Standard BSA contains variable endotoxin that activates cells in PBMC co-culture detection systems \u2014 low endotoxin grade is not optional.<\/p>\n    <\/div>\n  <\/div>\n\n  <div class=\"two\">\n    <div>\n      <h2>Human Serum AB vs FBS \u2014 which to use for PBMC assays<\/h2>\n      <p>The choice depends on whether the assay requires physiological relevance to the human immune environment or whether cost-effective endotoxin-controlled culture is sufficient.<\/p>\n      <p><strong>Human Serum AB HI is preferred<\/strong> when: the assay measures vaccine immunogenicity or clinical immune responses where species-matched matrix matters; bovine xenogenic proteins could stimulate non-specific immune responses; regulatory or clinical trial submissions require a human matrix; or opsonophagocytosis (OPA) assays require active human complement and IgG together.<\/p>\n      <p><strong>FBS Very Low Endotoxin<\/strong> is appropriate for routine research PBMC culture, Granzyme B\/Perforin ELISpot, multiplex cytokine assays, T cell proliferation, and Treg suppression assays \u2014 where cost is a constraint and the assay readout is not sensitive to bovine xenogenic background, provided endotoxin is controlled at \u22641 EU\/mL.<\/p>\n      <p><strong>Overnight rest before stimulation:<\/strong> PBMC isolation by Ficoll causes mechanical stress that primes cells for non-specific cytokine release. A 16\u201324 hour rest at 37\u00b0C in VLE FBS or Human Serum AB HI before stimulation consistently reduces ELISpot background spot counts. Do not change serum between rest and stimulation \u2014 serum change introduces variability.<\/p>\n      <p><strong>Cryopreservation:<\/strong> 90% FBS VLE or 90% Human Serum AB HI + 10% DMSO. VLE\/HI grade mandatory \u2014 endotoxin in standard FBS activates cells during freeze-thaw, reducing post-thaw viability and functional recovery.<\/p>\n    <\/div>\n    <div>\n      <h3>Recommended products<\/h3>\n      <ul>\n        <li><a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-type-ab-male\">Human Serum AB HI<\/a> \u2014 ELISpot, PBMC assays \u2014 first choice<\/li>\n        <li><a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-off-the-clot-type-ab\">Human Serum AB OTC<\/a> \u2014 OPA complement + opsonin source<\/li>\n        <li><a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-off-the-clot-type-ab-male\">Human Serum AB OTC Male<\/a> \u2014 NK &amp; T cell expansion<\/li>\n        <li><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">FBS Very Low Endotoxin \u22641 EU\/mL<\/a> \u2014 ELISpot, cytokine assays<\/li>\n        <li><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-ultra-low-igg-low-igg\">FBS Ultra Low IgG &lt;5 \u00b5g\/mL<\/a> \u2014 NK cell ADCC, CD107a<\/li>\n        <li><a href=\"https:\/\/www.seamlessbio.de\/products\/albumin-proteins\/bsa-low-endotoxin\">BSA Low Endotoxin<\/a> \u2014 ELISA blocking, flow cytometry buffer<\/li>\n      <\/ul>\n    <\/div>\n  <\/div>\n\n  <!-- ASSAY TYPES TABLE -->\n  <div class=\"sec\">\n    <h2>PBMC Assay Types \u2014 Serum Requirements<\/h2>\n    <div class=\"tw\">\n      <table>\n        <thead><tr><th>Assay Type<\/th><th>Recommended Serum<\/th><th>Why<\/th><th>Concentration<\/th><\/tr><\/thead>\n        <tbody>\n          <tr>\n            <td><strong>IFN-\u03b3 ELISpot<\/strong> (vaccine immunogenicity)<\/td>\n            <td><a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-type-ab-male\">Human Serum AB HI<\/a> or <a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">FBS VLE \u22641 EU\/mL<\/a><\/td>\n            <td>Endotoxin activates monocytes via TLR4 \u2192 non-specific IFN-\u03b3 spots. Human serum preferred \u2014 species-matched matrix reflects in vivo conditions.<\/td>\n            <td>5\u201310%<\/td>\n          <\/tr>\n          <tr>\n            <td><strong>Granzyme B \/ Perforin ELISpot<\/strong> (CTL)<\/td>\n            <td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">FBS VLE \u22641 EU\/mL<\/a><\/td>\n            <td>Endotoxin activates NK cells non-specifically via monocyte IL-12 \u2192 background degranulation spots independent of antigen-specific stimulation.<\/td>\n            <td>5\u201310%<\/td>\n          <\/tr>\n          <tr>\n            <td><strong>Multiplex cytokine assay<\/strong> (Luminex, MSD)<\/td>\n            <td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">FBS VLE \u22641 EU\/mL<\/a><\/td>\n            <td>Endotoxin drives monocyte IL-6, TNF-\u03b1, IL-1\u03b2 \u2192 elevates baseline cytokine levels in unstimulated controls, masking treatment effects.<\/td>\n            <td>5\u201310%<\/td>\n          <\/tr>\n          <tr>\n            <td><strong>T cell proliferation<\/strong> (CFSE, Ki67)<\/td>\n            <td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">FBS VLE \u22641 EU\/mL<\/a> or <a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-type-ab-male\">Human Serum AB HI<\/a><\/td>\n            <td>Endotoxin causes bystander T cell activation \u2192 inflates background proliferation in unstimulated wells.<\/td>\n            <td>5\u201310%<\/td>\n          <\/tr>\n          <tr>\n            <td><strong>NK cell cytotoxicity \/ ADCC<\/strong> (CD107a)<\/td>\n            <td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">FBS VLE \u22641 EU\/mL<\/a> + <a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-ultra-low-igg-low-igg\">FBS Ultra Low IgG<\/a> for ADCC<\/td>\n            <td>Endotoxin activates NK cells non-specifically. Bovine IgG in standard FBS occupies Fc\u03b3RIII (CD16) \u2192 reduces ADCC signal.<\/td>\n            <td>5\u201310%<\/td>\n          <\/tr>\n          <tr>\n            <td><strong>Monocyte \/ DC maturation<\/strong><\/td>\n            <td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">FBS VLE \u22641 EU\/mL<\/a><\/td>\n            <td>Monocytes are exquisitely LPS-sensitive \u2014 endotoxin in standard FBS drives spontaneous CD80\/CD86 upregulation independent of experimental stimuli.<\/td>\n            <td>5\u201310% differentiation; serum-free during stimulation<\/td>\n          <\/tr>\n          <tr>\n            <td><strong>Opsonophagocytosis (OPA)<\/strong><\/td>\n            <td><a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-off-the-clot-type-ab\">Human Serum AB OTC native<\/a><\/td>\n            <td>Requires active human complement + human IgG in the human Fc receptor pathway together \u2014 bovine serum cannot replicate this.<\/td>\n            <td>10\u201325% as complement\/opsonin source<\/td>\n          <\/tr>\n          <tr>\n            <td><strong>Treg suppression assay<\/strong><\/td>\n            <td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">FBS VLE \u22641 EU\/mL<\/a><\/td>\n            <td>Endotoxin activates effector T cells \u2192 impairs Treg suppressive function measurement and accurate Treg:Teff ratio determination.<\/td>\n            <td>5\u201310%<\/td>\n          <\/tr>\n        <\/tbody>\n      <\/table>\n    <\/div>\n  <\/div>\n\n  <!-- FBS vs HUMAN SERUM -->\n  <div class=\"sec\">\n    <h2>Human Serum AB HI vs FBS Very Low Endotoxin \u2014 Comparison<\/h2>\n    <div class=\"tw\">\n      <table>\n        <thead><tr><th>Criterion<\/th><th>FBS Very Low Endotoxin<\/th><th>Human Serum AB HI<\/th><\/tr><\/thead>\n        <tbody>\n          <tr><td><strong>Species match<\/strong><\/td><td>Bovine \u2014 xenogenic matrix<\/td><td>Human \u2014 physiological match for human immune cells<\/td><\/tr>\n          <tr><td><strong>Endotoxin<\/strong><\/td><td>\u22641 EU\/mL \u2014 controlled<\/td><td>Tested \u2014 low endotoxin lot selection<\/td><\/tr>\n          <tr><td><strong>Complement<\/strong><\/td><td>Present in non-HI \u2014 must use HI FBS for PBMC assays<\/td><td>Destroyed by 56\u00b0C\/30 min \u2014 no spontaneous complement lysis<\/td><\/tr>\n          <tr><td><strong>Cytokine background<\/strong><\/td><td>Low with VLE grade<\/td><td>Lower \u2014 no bovine cytokine cross-reactivity in human assays<\/td><\/tr>\n          <tr><td><strong>Vaccine immunogenicity ELISpot<\/strong><\/td><td>Acceptable<\/td><td>Preferred \u2014 human matrix reflects in vivo immunological conditions<\/td><\/tr>\n          <tr><td><strong>OPA assay<\/strong><\/td><td>\u2717 Not suitable<\/td><td>\u2705 Native OTC: human complement + human IgG required<\/td><\/tr>\n          <tr><td><strong>Cost<\/strong><\/td><td>Lower<\/td><td>Higher \u2014 gold standard for clinical immunology<\/td><\/tr>\n          <tr><td><strong>Donor variability<\/strong><\/td><td>Lot-to-lot FBS variability<\/td><td>Pool variability \u2014 AB Male donors recommended for consistency<\/td><\/tr>\n        <\/tbody>\n      <\/table>\n    <\/div>\n  <\/div>\n\n  <!-- ISOLATION PROTOCOL TABLE -->\n  <div class=\"sec\">\n    <h2>PBMC Isolation \u2014 Serum at Each Step<\/h2>\n    <div class=\"tw\">\n      <table>\n        <thead><tr><th>Step<\/th><th>Serum<\/th><th>Note<\/th><\/tr><\/thead>\n        <tbody>\n          <tr><td><strong>Ficoll density gradient<\/strong><\/td><td>No serum \u2014 PBS or RPMI without serum<\/td><td>Serum in the Ficoll layer reduces separation efficiency \u2014 omit entirely<\/td><\/tr>\n          <tr><td><strong>Wash steps<\/strong><\/td><td>RPMI without serum or 0.5% BSA Low Endotoxin<\/td><td>Minimal protein \u2014 prevents premature cell activation during washing<\/td><\/tr>\n          <tr><td><strong>Rest \/ recovery culture (2\u201324h)<\/strong><\/td><td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">FBS VLE \u22641 EU\/mL<\/a> or <a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-type-ab-male\">Human Serum AB HI<\/a> at 5\u201310%<\/td><td>Overnight rest reduces isolation-induced activation \u2014 critical for low background ELISpot results<\/td><\/tr>\n          <tr><td><strong>Stimulation &amp; assay culture<\/strong><\/td><td>Same serum as rest culture throughout<\/td><td>Do not change serum between rest and stimulation \u2014 introduces variability<\/td><\/tr>\n          <tr><td><strong>Cryopreservation<\/strong><\/td><td>90% FBS VLE or 90% Human Serum AB HI + 10% DMSO<\/td><td>High serum concentration for cryoprotection. VLE\/HI mandatory \u2014 standard FBS endotoxin activates cells during freeze-thaw<\/td><\/tr>\n        <\/tbody>\n      <\/table>\n    <\/div>\n  <\/div>\n\n  <!-- BSA TABLE -->\n  <div class=\"sec\">\n    <h2>BSA in PBMC-Based Immunology Assays<\/h2>\n    <div class=\"tw\">\n      <table>\n        <thead><tr><th>Application<\/th><th>Product<\/th><th>Concentration<\/th><th>Function<\/th><\/tr><\/thead>\n        <tbody>\n          <tr><td><strong>ELISA blocking buffer<\/strong> (cytokine detection)<\/td><td><a href=\"https:\/\/www.seamlessbio.de\/products\/albumin-proteins\/bsa-low-endotoxin\">BSA Low Endotoxin \u22645 EU\/mg<\/a><\/td><td>1\u20133% in PBS-T<\/td><td>Prevents non-specific binding in cytokine ELISA \u2014 low endotoxin mandatory to avoid cell activation during blocking in co-culture detection formats<\/td><\/tr>\n          <tr><td><strong>Flow cytometry staining buffer<\/strong><\/td><td><a href=\"https:\/\/www.seamlessbio.de\/products\/albumin-proteins\/bsa-low-endotoxin\">BSA Low Endotoxin<\/a><\/td><td>0.5\u20132%<\/td><td>Protein carrier in cell staining buffer \u2014 prevents non-specific antibody binding to Fc receptors on PBMCs<\/td><\/tr>\n          <tr><td><strong>BCA \/ Bradford protein standard<\/strong><\/td><td><a href=\"https:\/\/www.seamlessbio.de\/products\/albumin-proteins\/bsa-low-endotoxin\">BSA Low Endotoxin<\/a> or <a href=\"https:\/\/www.seamlessbio.de\/products\/albumin-proteins\/bsa-ph-5-2\">BSA pH 5.2<\/a><\/td><td>Calibration curve<\/td><td>Matrix-matched protein standard for BCA and Bradford assay. BSA pH 5.2 for pH-specific buffer compatibility in cytokine standard curve preparation.<\/td><\/tr>\n        <\/tbody>\n      <\/table>\n    <\/div>\n  <\/div>\n\n  <!-- FAQ -->\n  <div class=\"faq\">\n    <h2>Frequently Asked Questions<\/h2>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">Why is standard FBS not suitable for ELISpot assays?<\/div>\n      <div class=\"faq-a\">Standard FBS contains variable endotoxin levels \u2014 typically 10\u2013100 EU\/mL in unselected lots. Endotoxin activates monocytes and macrophages in PBMC preparations via TLR4, triggering non-specific IFN-\u03b3, TNF-\u03b1 and IL-6 secretion. In IFN-\u03b3 ELISpot assays this creates elevated background spot counts in unstimulated wells \u2014 reducing signal-to-noise and masking antigen-specific T cell responses. FBS Very Low Endotoxin \u22641 EU\/mL (or Human Serum AB HI) eliminates this non-specific monocyte activation and is the minimum requirement for valid ELISpot results.<\/div>\n    <\/div>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">When is Human Serum AB HI preferred over FBS VLE for PBMC assays?<\/div>\n      <div class=\"faq-a\">Human Serum AB HI is preferred when: (1) the assay measures vaccine immunogenicity or clinical immune responses where species-matched matrix matters \u2014 bovine serum matrix can stimulate xenogenic T cell responses that obscure antigen-specific signals; (2) bovine xenogenic proteins could non-specifically stimulate immune responses in the assay; (3) the assay is for clinical trial immunomonitoring or regulatory submission where a human matrix is required. For routine research PBMC culture and non-antigen-specific assays, FBS VLE is cost-effective and acceptable.<\/div>\n    <\/div>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">How does overnight rest improve ELISpot results?<\/div>\n      <div class=\"faq-a\">Ficoll density gradient centrifugation causes mechanical stress, temperature variation, and activation signals from the hyperosmotic gradient medium \u2014 priming cells for non-specific cytokine release. A 16\u201324 hour rest culture at 37\u00b0C in VLE FBS or Human Serum AB HI allows this isolation-induced activation to subside before antigen stimulation. Labs that rest PBMCs consistently report lower background spot counts and higher signal-to-noise ratios in antigen-specific ELISpot assays compared to immediate stimulation post-isolation.<\/div>\n    <\/div>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">What serum is correct for PBMC cryopreservation?<\/div>\n      <div class=\"faq-a\">90% FBS Very Low Endotoxin + 10% DMSO is the standard cryopreservation medium for PBMCs. The high serum concentration (90%) provides the protein matrix required for cryoprotection \u2014 serum proteins stabilise cell membranes during ice crystal formation and protect against osmotic damage during thawing. VLE grade is mandatory because endotoxin in standard FBS activates cells during the slow-cool freeze-thaw cycle \u2014 reducing post-thaw viability and functional recovery. For xeno-free protocols: 90% Human Serum AB HI + 10% DMSO.<\/div>\n    <\/div>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">Why does the OPA assay specifically require Human Serum AB OTC native?<\/div>\n      <div class=\"faq-a\">Opsonophagocytosis assays measure the ability of antibodies to opsonise a pathogen for phagocytic killing \u2014 requiring two human-specific components working together: human complement (C3b deposition for CR3-mediated phagocytosis) and human IgG (Fc\u03b3R-mediated phagocytosis). Bovine serum does not contain the correct complement pathway components, and bovine IgG does not engage human Fc receptors with sufficient affinity for OPA. Human Serum AB OTC native is the only matrix that provides both active human complement and human IgG simultaneously \u2014 the AB blood type ensures no anti-A or anti-B antibodies that would cause non-specific RBC lysis in some OPA formats.<\/div>\n    <\/div>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">Is Human Serum AB available from EU donors?<\/div>\n      <div class=\"faq-a\">Yes \u2014 SeamlessBio supplies Human Serum Type AB from EU-certified blood donor centres with full viral testing documentation per lot: HIV-1\/2, HBV, HCV, CMV, EBV, and Parvovirus B19. EU and US origin both available. All lots include Certificate of Analysis (CoA), Certificate of Origin (CoO) and viral testing panel. Batch reservation available for extended immunology study campaigns requiring consistent serum across multiple experiments.<\/div>\n    <\/div>\n  <\/div>\n\n  <!-- RELATED -->\n  <div class=\"related\">\n    <h3>Related Applications &amp; Products<\/h3>\n    <div class=\"rel-grid\">\n      <a href=\"https:\/\/www.seamlessbio.de\/applications\/cytotoxicity-assays\">\u2192 Cytotoxicity Assays \u2014 ADCC, CDC, ELISpot<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/applications\/car-t-cell-manufacturing\">\u2192 CAR-T Cell Manufacturing Guide<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-type-ab-male\">\u2192 Human Serum AB HI<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-off-the-clot-type-ab\">\u2192 Human Serum AB OTC<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">\u2192 FBS Very Low Endotoxin \u22641 EU\/mL<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/products\/albumin-proteins\/bsa-low-endotoxin\">\u2192 BSA Low Endotoxin<\/a>\n    <\/div>\n  <\/div>\n\n  <!-- CTA -->\n  <!-- HUB BACKLINK -->\n  <div style=\"text-align:center;padding:20px 0 0;border-top:1px solid rgba(24,183,178,.15);margin-bottom:16px;\">\n    <a href=\"https:\/\/www.seamlessbio.de\/applications\/\" style=\"display:inline-flex;align-items:center;gap:8px;color:#18b7b2;font-size:14px;font-weight:700;text-decoration:none;\">\n      \u2190 All Application Guides Overview\n    <\/a>\n  <\/div>\n\n  <div class=\"cta\">\n    <h2>Request Free Test Volumes for PBMC Assay Validation<\/h2>\n    <p>Human Serum AB HI and OTC lot-specific endotoxin and viral testing data available on request. Free test samples for ELISpot and PBMC assay validation. Batch reservation for extended immunology campaigns.<br>Email: info@seamlessbio.de | +49 851 37932226<\/p>\n    <div class=\"ctabtns\">\n      <a href=\"mailto:info@seamlessbio.de\" class=\"ctab1\">Contact Us<\/a>\n      <a href=\"https:\/\/shop.seamlessbio.de\" class=\"ctab2\">View in Shop<\/a>\n    <\/div>\n  <\/div>\n<\/div>\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"FAQPage\",\n      \"@id\": \"https:\/\/www.seamlessbio.de\/applications\/pbmc-immunology#faqpage\",\n      \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Why is standard FBS not suitable for ELISpot assays?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Standard FBS contains variable endotoxin levels \u2014 typically 10\u2013100 EU\/mL in unselected lots. Endotoxin activates monocytes and macrophages in PBMC preparations via TLR4, triggering non-specific IFN-\u03b3, TNF-\u03b1 and IL-6 secretion. In IFN-\u03b3 ELISpot assays this creates elevated background spot counts in unstimulated wells \u2014 reducing signal-to-noise and masking antigen-specific T cell responses. FBS Very Low Endotoxin \u22641 EU\/mL (or Human Serum AB HI) eliminates this non-specific monocyte activation and is the minimum requirement for valid ELISpot results.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"When is Human Serum AB HI preferred over FBS VLE for PBMC assays?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Human Serum AB HI is preferred when: (1) the assay measures vaccine immunogenicity or clinical immune responses where species-matched matrix matters \u2014 bovine serum matrix can stimulate xenogenic T cell responses that obscure antigen-specific signals; (2) bovine xenogenic proteins could non-specifically stimulate immune responses in the assay; (3) the assay is for clinical trial immunomonitoring or regulatory submission where a human matrix is required. For routine research PBMC culture and non-antigen-specific assays, FBS VLE is cost-effective and acceptable.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How does overnight rest improve ELISpot results?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Ficoll density gradient centrifugation causes mechanical stress, temperature variation, and activation signals from the hyperosmotic gradient medium \u2014 priming cells for non-specific cytokine release. A 16\u201324 hour rest culture at 37\u00b0C in VLE FBS or Human Serum AB HI allows this isolation-induced activation to subside before antigen stimulation. Labs that rest PBMCs consistently report lower background spot counts and higher signal-to-noise ratios in antigen-specific ELISpot assays compared to immediate stimulation post-isolation.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What serum is correct for PBMC cryopreservation?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"90% FBS Very Low Endotoxin + 10% DMSO is the standard cryopreservation medium for PBMCs. The high serum concentration (90%) provides the protein matrix required for cryoprotection \u2014 serum proteins stabilise cell membranes during ice crystal formation and protect against osmotic damage during thawing. VLE grade is mandatory because endotoxin in standard FBS activates cells during the slow-cool freeze-thaw cycle \u2014 reducing post-thaw viability and functional recovery. For xeno-free protocols: 90% Human Serum AB HI + 10% DMSO.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Why does the OPA assay specifically require Human Serum AB OTC native?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Opsonophagocytosis assays measure the ability of antibodies to opsonise a pathogen for phagocytic killing \u2014 requiring two human-specific components working together: human complement (C3b deposition for CR3-mediated phagocytosis) and human IgG (Fc\u03b3R-mediated phagocytosis). Bovine serum does not contain the correct complement pathway components, and bovine IgG does not engage human Fc receptors with sufficient affinity for OPA. Human Serum AB OTC native is the only matrix that provides both active human complement and human IgG simultaneously \u2014 the AB blood type ensures no anti-A or anti-B antibodies that would cause non-specific RBC lysis in some OPA formats.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is Human Serum AB available from EU donors?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Yes \u2014 SeamlessBio supplies Human Serum Type AB from EU-certified blood donor centres with full viral testing documentation per lot: HIV-1\/2, HBV, HCV, CMV, EBV, and Parvovirus B19. EU and US origin both available. All lots include Certificate of Analysis (CoA), Certificate of Origin (CoO) and viral testing panel. Batch reservation available for extended immunology study campaigns requiring consistent serum across multiple experiments.\"\n      }\n    }\n      ]\n    },\n    {\n      \"@type\": \"BreadcrumbList\",\n      \"@id\": \"https:\/\/www.seamlessbio.de\/applications\/pbmc-immunology#breadcrumb\",\n      \"itemListElement\": [\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 1,\n          \"name\": \"Home\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/\"\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 2,\n          \"name\": \"Applications\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/applications\/\"\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 3,\n          \"name\": \"PBMC & Immunology Assays\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/applications\/pbmc-immunology\"\n        }\n      ]\n    }\n  ]\n}\n<\/script>\n<\/section>\t\t\t\t<\/div>\n\t\t\n<\/div>\n\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Home\/ Applications\/ PBMC Immunology SeamlessBio \u2014 Solutions by Application PBMC Culture &amp; Immunology Assays \u2014 Serum Selection Guide Peripheral blood mononuclear cells (PBMCs) are the primary cell system for human [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_eb_attr":"","footnotes":""},"class_list":["post-1751","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PBMC &amp; Immunology Assays Human Serum Serum Selection<\/title>\n<meta name=\"description\" content=\"Human Serum AB HI and OTC for ELISpot and PBMC assays. FBS Very Low Endotoxin \u22641 EU\/mL as alternative. Lot-specific data on request.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/seamlessbio.de\/de\/pbmc\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PBMC &amp; Immunology Assays Human Serum Serum Selection\" \/>\n<meta property=\"og:description\" content=\"Human Serum AB HI and OTC for ELISpot and PBMC assays. FBS Very Low Endotoxin \u22641 EU\/mL as alternative. Lot-specific data on request.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/seamlessbio.de\/de\/pbmc\/\" \/>\n<meta property=\"og:site_name\" content=\"SeamlessBio\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-06T20:32:37+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"8\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/pbmc\\\/\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/pbmc\\\/\",\"name\":\"PBMC & Immunology Assays Human Serum Serum Selection\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\"},\"datePublished\":\"2026-06-26T18:11:28+00:00\",\"dateModified\":\"2026-07-06T20:32:37+00:00\",\"description\":\"Human Serum AB HI and OTC for ELISpot and PBMC assays. FBS Very Low Endotoxin \u22641 EU\\\/mL as alternative. Lot-specific data on request.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/pbmc\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/seamlessbio.de\\\/pbmc\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/pbmc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/seamlessbio.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Application PBMC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"name\":\"SeamlessBio\",\"description\":\"Expert for biological materials for pharma, vaccines and research organizations\",\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/seamlessbio.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\",\"name\":\"SeamlessBio\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png\",\"contentUrl\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png\",\"width\":309,\"height\":88,\"caption\":\"SeamlessBio\"},\"image\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PBMC & Immunology Assays Human Serum Serum Selection","description":"Human Serum AB HI and OTC for ELISpot and PBMC assays. FBS Very Low Endotoxin \u22641 EU\/mL as alternative. Lot-specific data on request.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/seamlessbio.de\/de\/pbmc\/","og_locale":"de_DE","og_type":"article","og_title":"PBMC & Immunology Assays Human Serum Serum Selection","og_description":"Human Serum AB HI and OTC for ELISpot and PBMC assays. FBS Very Low Endotoxin \u22641 EU\/mL as alternative. Lot-specific data on request.","og_url":"https:\/\/seamlessbio.de\/de\/pbmc\/","og_site_name":"SeamlessBio","article_modified_time":"2026-07-06T20:32:37+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"8\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/seamlessbio.de\/pbmc\/","url":"https:\/\/seamlessbio.de\/pbmc\/","name":"PBMC & Immunology Assays Human Serum Serum Selection","isPartOf":{"@id":"https:\/\/seamlessbio.de\/#website"},"datePublished":"2026-06-26T18:11:28+00:00","dateModified":"2026-07-06T20:32:37+00:00","description":"Human Serum AB HI and OTC for ELISpot and PBMC assays. FBS Very Low Endotoxin \u22641 EU\/mL as alternative. Lot-specific data on request.","breadcrumb":{"@id":"https:\/\/seamlessbio.de\/pbmc\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/seamlessbio.de\/pbmc\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/seamlessbio.de\/pbmc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/seamlessbio.de\/"},{"@type":"ListItem","position":2,"name":"Application PBMC"}]},{"@type":"WebSite","@id":"https:\/\/seamlessbio.de\/#website","url":"https:\/\/seamlessbio.de\/","name":"SeamlessBio","description":"Experte f\u00fcr biologische Materialien f\u00fcr die Pharmaindustrie, Impfstoffe und Forschungseinrichtungen","publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/seamlessbio.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/seamlessbio.de\/#organization","name":"SeamlessBio","url":"https:\/\/seamlessbio.de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/seamlessbio.de\/#\/schema\/logo\/image\/","url":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png","contentUrl":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png","width":309,"height":88,"caption":"SeamlessBio"},"image":{"@id":"https:\/\/seamlessbio.de\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/1751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/comments?post=1751"}],"version-history":[{"count":13,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/1751\/revisions"}],"predecessor-version":[{"id":1896,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/1751\/revisions\/1896"}],"wp:attachment":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/media?parent=1751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}